Tirzepatide uses

Tirzepatide is a prescription medicine used for chronic weight management and to treat obstructive sleep apnea in adults with obesity, always as an addition to a reduced-calorie diet and increased physical activity . It is important to know that tirzepatide is available under two brand names for different primary indications, although the medication itself is the same .

The table below summarizes the approved uses for tirzepatide under its different brand names .

Brand Name Primary Indication Details & Criteria
Mounjaro® Improve blood sugar control in adults with type 2 diabetes . Used in addition to diet and exercise .
Zepbound® Chronic weight management in adults with obesity or overweight . For adults with a BMI of 30 kg/m² or greater (obesity), or a BMI of 27 kg/m² or greater (overweight) with at least one weight-related condition (e.g., high blood pressure, type 2 diabetes, high cholesterol) .
Zepbound® Treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity . This was a newer approval, announced in late 2024 and early 2025 . It is the first FDA-approved medication for this condition in this specific patient group .

The effectiveness of tirzepatide has been demonstrated in clinical trials:

· For Weight Management: In the SURMOUNT-1 trial, adults without diabetes taking the highest dose (15 mg) lost an average of 48 pounds over 72 weeks, compared to 7 pounds with placebo . Another source notes that over a year, weight loss can range from 15% to nearly 21% of total body weight, depending on the dose .
· For Obstructive Sleep Apnea: In the SURMOUNT-OSA trials, tirzepatide significantly reduced the number of times breathing stopped per hour. Depending on the study group, patients experienced about 25 to 29 fewer breathing interruptions per hour, compared to about 5 with placebo .

· How it's taken: Tirzepatide is a once-weekly injection under the skin (subcutaneous) of the abdomen, thigh, or upper arm . It's crucial to follow the dosage schedule prescribed by your doctor, which typically starts at a low dose and increases gradually .
· Common side effects: The most frequent side effects are gastrointestinal, including nausea, diarrhea, vomiting, and constipation . These are often temporary and can be managed by eating smaller meals .
· Serious risks: Tirzepatife has a Boxed Warning about the risk of thyroid C-cell tumors. It should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) .
· Drug interactions: This medication can slow stomach emptying, which may affect how other oral medications, including birth control pills, are absorbed. Your doctor may recommend using a different or additional form of contraception for a period of time .